Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First component of complement and thrombosis

J L Wautier, M P Ollier-Hartmann, H Kadeva

    Thrombosis and Haemostasis
    |June 30, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

    La Revue de medecine interne·2023
    Same author

    [Importance of cognitive disorders in internal medicine: Pathophysiology, diagnosis, management. The example of systemic lupus erythematosus].

    La Revue de medecine interne·2021
    Same author

    [Towards a better recognition of cognitive disorders in internal medicine?]

    La Revue de medecine interne·2021
    Same author

    Infective endocarditis due to Neisseria elongata: A case report and literature review.

    Infectious diseases now·2021
    Same author

    [Incidental pneumonia on PET imaging].

    La Revue de medecine interne·2020
    Same author

    Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.

    Clinical immunology (Orlando, Fla.)·2018
    Same journal

    Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

    Thrombosis and haemostasis·2026
    Same journal

    The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

    Thrombosis and haemostasis·2026
    Same journal

    Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

    Thrombosis and haemostasis·2026
    Same journal

    Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

    Thrombosis and haemostasis·2026
    Same journal

    Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

    Thrombosis and haemostasis·2026
    Same journal

    Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

    Thrombosis and haemostasis·2026
    See all related articles

    The first component of complement (C1) may modulate platelet-collagen interactions, potentially influencing thrombosis. Reduced platelet C1q in patients with complement abnormalities correlated with increased collagen-induced aggregation, suggesting a link to thromboembolic events.

    Area of Science:

    • Immunology
    • Hematology
    • Complement System

    Background:

    • The collagen-like region of C1q, a complement component, interacts with human platelets.
    • C1q inhibits platelet adhesion and aggregation induced by collagen.
    • Collagen is a key component of the vessel wall, suggesting C1's role in thrombosis.

    Observation:

    • Two patients with acquired angioneurotic edema and complement abnormalities (low C1, C4, C2; C1 inhibitor deficiency) experienced recurrent arterial/venous thrombosis.
    • Platelet-associated C1q was found to be decreased or undetectable in these patients.

    Findings:

    • A decrease in platelet-associated C1q was observed.
    • This reduction was associated with a specific increase in collagen-induced platelet aggregation.

    Related Experiment Videos

    Implications:

    • Reduced C1q may impair the modulation of platelet-collagen interaction.
    • This impairment could represent a mechanism contributing to recurrent thromboembolic episodes.
    • Further research into C1q's role in thrombosis is warranted.